Get a glimpse into our company and investor data—powered by the PitchBook Platform
Developer of vascularizable biodebradable prostheses designed to offer a natural breast reconstruction or augmentation. The company's vascularizable biodebradable prostheses offers porous implantable prostheses based on biodegradable synthetic biomaterials and fabricated with internal mirco-channels mimicking the blood-vessels architecture for the treatment of breast cancer, enabling breast cancer patients to improve their quality of life and avoid recurrent and expensive surgical operations.
You’re viewing a free company profile from the PitchBook Platform. To explore Tensive’s full profile, request a free trial.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Grant | 20-Jun-2016 | $56.2K | 00.000 | Completed | Pre-Clinical Trials | |
2. Early Stage VC | 20-May-2016 | 00.000 | 00.000 | Completed | Pre-Clinical Trials | |
1. Accelerator/Incubator | 01-Jan-2012 | Completed | Pre-Clinical Trials |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
---|---|---|---|---|---|---|
Horizon 2020 | Government | 000 0000 | 000000 0 | |||
Invitalia Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | ||
Marzotto Family | Family Office | Minority | 000 0000 | 000000 0 | ||
Rancilio Cube | Family Office | Minority | 000 0000 | 000000 0 | ||
UniCredit | Investment Bank | Minority | 000 0000 | 000000 0 |
Name | Representing | Role | Since | Contact Info |
---|---|---|---|---|
Alberto Cantaluppi MD | Tensive | Chairman | 000 0000 | |
Alessandro Tocchio Ph.D | Self | Co-Founder & Board Member | 000 0000 | |
Irini Gerges Ph.D | Tensive | Co-Founder, Chief Technology Officer & Director, Research & Development & Board Member | 000 0000 | |
Mario Salerno Ph.D | Self | Board Member | 000 0000 |